Patents by Inventor Joanne T. Trojnacki

Joanne T. Trojnacki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human KCNQ5 potassium channel, methods and compositions thereof
    Publication number: 20090005304
    Abstract: An isolated polynucleotide encoding a novel potassium channel polypeptide, KCNQ5, that is expressed primarily in brain and skeletal muscle is described. The new polypeptide has been cloned and isolated from a human brain cDNA library and is a member the KCNQ family of potassium channels. The provided human KCNQ5 nucleic acid sequence and encoded polypeptide can be employed for diagnostic, screening and therapeutic uses.
    Type: Application
    Filed: June 28, 2007
    Publication date: January 1, 2009
    Inventors: Steven I. Dworetzky, Chandra S. Ramanathan, Joanne T. Trojnacki, Christopher G. Boissard, Valentin K. Gribkoff
  • Human kcnq5 potassium channel, methods and compositions thereof
    Patent number: 6893858
    Abstract: An isolated polynucleotide encoding a novel potassium channel polypeptide, KCNQ5, that is expressed primarily in brain and skeletal muscle is described. The new polypeptide has been cloned and isolated from a human brain cDNA library and is a member the KCNQ family of potassium channels. The provided human KCNQ5 nucleic acid sequence and encoded polypeptide can be employed for diagnostic, screening and therapeutic uses.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: May 17, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Steven I. Dworetzky, Chandra S. Ramanathan, Joanne T. Trojnacki, Valentin K. Gribkoff
  • Human kcnq5 potassium channel, methods and compositions thereof
    Publication number: 20020040000
    Abstract: An isolated polynucleotide encoding a novel potassium channel polypeptide, KCNQ5, that is expressed primarily in brain and skeletal muscle is described. The new polypeptide has been cloned and isolated from a human brain cDNA library and is a member the KCNQ family of potassium channels. The provided human KCNQ5 nucleic acid sequence and encoded polypeptide can be employed for diagnostic, screening and therapeutic uses.
    Type: Application
    Filed: May 24, 2001
    Publication date: April 4, 2002
    Inventors: Steven I. Dworetzky, Chandra S. Ramanathan, Joanne T. Trojnacki, Christopher G. Boissard, Valentin K. Gribkoff